SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 193 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,434 | +265.8% | 141 | +243.9% | 0.00% | – |
| Q4 2022 | $5,313 | -51.7% | 41 | -70.9% | 0.00% | – |
| Q2 2021 | $11,000 | -54.2% | 141 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $24,000 | -33.3% | 141 | -44.7% | 0.00% | -50.0% |
| Q3 2020 | $36,000 | -10.0% | 255 | -37.7% | 0.00% | -33.3% |
| Q1 2020 | $40,000 | -4.8% | 409 | +27.0% | 0.00% | +50.0% |
| Q4 2019 | $42,000 | +425.0% | 322 | +531.4% | 0.00% | – |
| Q3 2019 | $8,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -97.5% | 51 | -98.1% | 0.00% | -100.0% |
| Q1 2019 | $320,000 | +9.2% | 2,684 | 0.0% | 0.02% | -15.4% |
| Q4 2018 | $293,000 | -36.2% | 2,684 | -5.6% | 0.03% | -21.2% |
| Q3 2018 | $459,000 | +42.1% | 2,843 | +10.1% | 0.03% | +32.0% |
| Q2 2018 | $323,000 | -20.4% | 2,583 | -52.9% | 0.02% | -21.9% |
| Q1 2018 | $406,000 | +33.1% | 5,483 | 0.0% | 0.03% | +18.5% |
| Q4 2017 | $305,000 | +3712.5% | 5,483 | +2093.2% | 0.03% | +2600.0% |
| Q2 2017 | $8,000 | -11.1% | 250 | -45.1% | 0.00% | -50.0% |
| Q2 2016 | $9,000 | 0.0% | 455 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $9,000 | -10.0% | 455 | +68.5% | 0.00% | -33.3% |
| Q4 2015 | $10,000 | +11.1% | 270 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $9,000 | – | 270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |